Drug details

Airsupra (albuterol and budesonide inhalation aerosol, for oral inhalation)

type of Respiratory Inhalant Combos

Airsupra (albuterol and budesonide) is a combination of a beta2-adrenergic agonist and a corticosteroid indicated for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in patients with asthma 18 years of age and older.

The drug is often used to treat Asthma .

This drug may have the following side effects:
  • hives,
  • difficulty breathing,
  • swelling of your face, lips, tongue, or throat,
  • nausea,
  • rash,
  • vomiting,
  • fever,
  • chills,
  • tiredness,
  • chest pain,
  • weakness, and
  • back pain,
  • worsening trouble breathing,
  • coughing,
  • wheezing,
  • fast or abnormal heart rate,
  • high blood pressure,
  • redness or swelling,
  • severe itching,
  • flu-like symptoms,
  • white spots in your mouth or throat,
  • bone fracture,
  • loss of height, 
  • fatigue,
  • vision changes
The following drugs are related to Airsupra, either as a replacement or used together:
  • Albuterol Sulfate (albuterol sulfate inhalation solution)
  • Proair HFA (albuterol sulfate inhalation aerosol)
  • ProAir Respiclick (albuterol sulfate inhalation powder)
  • Proair Digihaler (albuterol sulfate inhalation powder)
  • Albuterol Sulfate Tablets (albuterol sulfate tablets)
  • Atrovent HFA (ipratropium bromide inhalation aerosol)
  • Atrovent Nasal Spray (ipratropium bromide nasal spray)
  • Atrovent Nasal Spray .06 (ipratropium bromide nasal spray .06)
  • Fasenra (benralizumab for subcutaneous injection)
  • Breo Ellipta (fluticasone furoate and vilanterol inhalation powder)
  • Eucrisa Ointment (crisaborole)
  • Dupixent (dupilumab injection)
  • Wixela Inhub (fluticasone propionate and salmeterol inhalation powder)
  • Nucala (mepolizumab for injection)